Rising Malnutrition to Bolster the Global Clinical Nutrition Market to Garner $48.58 Billion by 2028

According to an analysis by Triton Market Research, the global clinical nutrition market, which was valued at $30.60 billion in 2019, is predicted to showcase a CAGR of 5.27% by 2028.

A study by Triton Market Research with the title ‘Global Clinical Nutrition Market,’ covers the Global Analysis and Forecast for 2019-2028 by Application (Metabolic Disorders, Gastrointestinal Disorders, Cancer, Neurological Disorders, Other Applications), by End-user (Geriatric, Adults, Pediatric), by Route of Administration (Oral, Enteral, Parenteral), and by Geographical Region (Latin America, Asia-Pacific, Europe, North America, Middle East and Africa).

Request Free Sample of the Global Clinical Nutrition Market Report @

According to the report, the global clinical nutrition market is expected to generate a revenue of $48.58 billion by the year 2028, progressing with a CAGR of 5.27% in the forecast period between 2019 and 2028.

Clinical nutrition products are supplements that help patients to enhance their body mechanism and provide an adequate nutritional intake, which they are unable to get from their regular diets. They aim at maintaining a healthy energy balance in the body.

The surging number of malnutrition victims is primarily driving the growth of the clinical nutrition market in the forecast period. Malnutrition is a condition occurring due to the deficiency of the required nutrients in the body. It is a widespread problem that is affecting millions of people across the world. Clinical nutrition is considered to be the most effective way to treat malnutrition by meeting the high caloric needs, which helps avoid associated costs. However, the lack of awareness about the availability of clinical nutrition in both developed and developing countries is restricting the market growth. Awareness campaigns are being increasingly conducted to promote awareness regarding the benefits of clinical nutrition.

The clinical nutrition market is segmented into application, end-user and route of administration. The first segment, application, include metabolic disorders, gastrointestinal disorders, cancer, neurological disorders and other applications. The second segment, end-user, is trifurcated into geriatric, adults and pediatric. The last segment, route of administration, includes oral, enteral and parenteral.

The Asia-Pacific is anticipated to be the fastest-growing region in the global clinical nutrition market over the projected period. The region is densely populated, and is thus witnessing an increasing demand for better healthcare infrastructure. The upsurge in the number of hospitals in developing countries, the rigorous R&D activities, rising healthcare reforms, and advancements in the field of healthcare are other factors driving the clinical nutrition market growth in the Asia-Pacific. Obesity is a major health concern in countries like China, South Korea and Japan. It is a major factor in metabolic disorders like diabetes. Patients with diabetes may require the intake of additional supplements to maintain the body-energy balance. Hence, there is an increasing need for clinical nutrition in these countries. Besides, obesity may also lead to cardiovascular disease and high blood pressure. This is also contributing to the rising demand for clinical nutrition in the Asia-Pacific.

A few prominent names in the clinical nutrition market are Abbott Laboratories, B Braun, Sichuan Kelun Pharmaceutical Co Ltd, Otsuka Holdings Co Ltd, Nestle Health Science, Avadel Pharmaceuticals, Danone, Grifols SA, Reckitt Benckiser Group Plc, BASF SE, Meiji Holdings Co Ltd, Lonza Inc, Exela Pharma Sciences, Sanofi SA, American Regent Inc and Baxter International Inc.

Purchase this Report @

Question & Answer: Clinical Nutrition Market

Question 1: Which factor is primarily driving the growth of the clinical nutrition market in the forecast period?
Answer: The surging number of malnutrition victims is primarily driving the growth of the clinical nutrition market in the forecast period. Malnutrition is a condition occurring due to the deficiency of required nutrients in the body. It is a widespread problem that is affecting millions of people across the world. Clinical nutrition is considered to be the most effective way to treat malnutrition by meeting the high caloric needs, which helps avoid associated costs.

Question 2: What factors are restricting the growth of the global clinical nutrition market?
Answer: The lack of awareness about the availability of clinical nutrition in both developed and developing countries is restricting the growth of the global clinical nutrition market. Awareness campaigns are being increasingly conducted to promote awareness regarding the benefits of clinical nutrition.

Question 3: In which way is Asia-Pacific influencing the global clinical nutrition market outlook?
Answer: The Asia-Pacific is anticipated to be the fastest-growing region in the global clinical nutrition market over the projected period. The region is densely populated, and is thus witnessing an increasing demand for better healthcare infrastructure. The upsurge in the number of hospitals in developing countries, the rigorous R&D activities, rising healthcare reforms, and advancements in the field of healthcare are other factors driving the clinical nutrition market growth in the Asia-Pacific.

Obesity is a major health concern in countries like China, South Korea and Japan. It is a major factor in metabolic disorders like diabetes. Patients with diabetes may require the intake of additional supplements to maintain the body-energy balance. Hence, there is an increasing need for clinical nutrition in these countries. Besides, obesity may also lead to cardiovascular disease and high blood pressure. This is also contributing to the rising demand for clinical nutrition in the Asia-Pacific.

Question 4: Which are a few prominent names in the clinical nutrition market?
Answer: A few prominent names in the clinical nutrition market are Abbott Laboratories, B Braun, Sichuan Kelun Pharmaceutical Co Ltd, Otsuka Holdings Co Ltd, Nestle Health Science, Avadel Pharmaceuticals, Danone, Grifols SA, Reckitt Benckiser Group Plc, BASF SE, Meiji Holdings Co Ltd, Lonza Inc, Exela Pharma Sciences, Sanofi SA, American Regent Inc and Baxter International Inc.

Related Report:
Global Animal Nutrition Market

The Global Animal Nutrition Market is estimated to generate $18.05 billion by the year 2028. The market is exhibiting a CAGR of 5.18% over the projected years 2019-2028.

There is an increasing demand for nutrient-rich meat among consumers across the globe, which has led to a rise in livestock production. The increase in the output and the high demand for animal-based products are generating a high return on investment for animal breeders. Manufacturers are increasingly focusing on investing in advanced technologies and developments. Therefore, the rising investments in new product developments are expected to create lucrative opportunities to the market over the forecast period.

The pet owners are increasingly visiting veterinarians due to the growing concern for animal health. The increasing animal health problems, like fertility issues, low energy and weak bone structure, are the major factors fuelling the sales of prescribed animal nutrition products. Other common illnesses among animals, like diarrhea and vomiting, are treated using chemicals and nutrients in animal feed. These factors have significantly increased the demand for animal nutrition market.

Triton Market Research
196, wards wharf approach
London E16 2EQ
Phone: +44 7441 911839
Email: sales@tritonmarketresearch.com
Website: https://www.tritonmarketresearch.com/

We are a leading market research company with offices in the UK, providing the best online market research and data search reports to our clients.

This release was published on openPR.